Kazan Organichesky sintez
Kazan Public Joint Stock Company Organichesky sintez, together with its subsidiaries, produces and sells chemical products in Russia. The last earnings update was 20 days ago. More info.
Add to Portfolio Compare Print
KZOS Share Price and Events
7 Day Returns
1 Year Returns
KZOS Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Kazan Organichesky sintez (KZOS) | 1.2% | 1% | 0.2% | 11.7% | 151.1% | 1317% |
| RU Chemicals | 0.9% | -0.4% | 1.9% | 6.2% | 4.1% | 94.7% |
| RU Market | -0.8% | 2.6% | 4.3% | 7.6% | 30.5% | 93.5% |
1 Year Return vs Industry and Market
- KZOS outperformed the Chemicals industry which returned 6.2% over the past year.
- KZOS outperformed the Market in Russian Federation which returned 7.6% over the past year.
KZOS Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Kazan Organichesky sintez
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Kazan Organichesky sintez.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Extrapolated from most recent financials. | See below |
| Discount Rate (Cost of Equity) | See below | 17.4% |
| Perpetual Growth Rate | 10-Year RU Government Bond Rate | 8.4% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year RU Govt Bond Rate | 8.4% |
| Equity Risk Premium | S&P Global | 9.4% |
| Chemicals Unlevered Beta | Simply Wall St/ S&P Global | 0.93 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.931 (1 + (1- 20%) (0%)) |
0.954 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.95 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 8.44% + (0.954 * 9.43%) |
17.44% |
Discounted Cash Flow Calculation for MISX:KZOS using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Kazan Organichesky sintez is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (RUB, Millions) | Source |
Present Value Discounted (@ 17.44%) |
|
|---|---|---|---|
| 2019 | 9,327.93 | Est @ -22.83% | 7,942.94 |
| 2020 | 8,073.13 | Est @ -13.45% | 5,853.75 |
| 2021 | 7,517.34 | Est @ -6.88% | 4,641.44 |
| 2022 | 7,345.41 | Est @ -2.29% | 3,861.90 |
| 2023 | 7,413.80 | Est @ 0.93% | 3,319.11 |
| 2024 | 7,649.83 | Est @ 3.18% | 2,916.28 |
| 2025 | 8,014.01 | Est @ 4.76% | 2,601.49 |
| 2026 | 8,483.99 | Est @ 5.86% | 2,345.14 |
| 2027 | 9,047.08 | Est @ 6.64% | 2,129.48 |
| 2028 | 9,696.48 | Est @ 7.18% | 1,943.46 |
| Present value of next 10 years cash flows | RUB37,554.98 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= RUB9,696.48 × (1 + 8.44%) ÷ (17.44% – 8.44%) |
RUB116,874.46 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= RUB116,874.46 ÷ (1 + 17.44%)10 |
RUB23,425.07 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= RUB37,554.98 + RUB23,425.07 |
RUB60,980.05 |
| Equity Value per Share (RUB) |
= Total value / Shares Outstanding
= RUB60,980.05 / 1,785.11 |
RUB34.16 |
| Calculation | Result | |
|---|---|---|
| Value per share (RUB) | From above. | RUB34.16 |
| Current discount | Discount to share price of
RUB100.20
= -1 x (RUB100.20 - RUB34.16) / RUB34.16 |
-193.3% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Kazan Organichesky sintez is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Kazan Organichesky sintez's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Kazan Organichesky sintez's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in RUB | RUB11.23 |
| MISX:KZOS Share Price ** | MISX (2019-04-18) in RUB | RUB100.2 |
| Russian Federation Chemicals Industry PE Ratio | Median Figure of 6 Publicly-Listed Chemicals Companies | 11.5x |
| Russian Federation Market PE Ratio | Median Figure of 130 Publicly-Listed Companies | 7.39x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Kazan Organichesky sintez.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = MISX:KZOS Share Price ÷ EPS (both in RUB) = 100.2 ÷ 11.23 |
8.92x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Kazan Organichesky sintez is good value based on earnings compared to the RU Chemicals industry average.
- Kazan Organichesky sintez is overvalued based on earnings compared to the Russian Federation market.
Price based on expected Growth
Does
Kazan Organichesky sintez's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 8.92x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts |
4.3%per year |
| Europe Chemicals Industry PEG Ratio | Median Figure of 62 Publicly-Listed Chemicals Companies | 1.89x |
| Russian Federation Market PEG Ratio | Median Figure of 33 Publicly-Listed Companies | 0.51x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Kazan Organichesky sintez, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Kazan Organichesky sintez's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in RUB | RUB37.70 |
| MISX:KZOS Share Price * | MISX (2019-04-18) in RUB | RUB100.2 |
| Russian Federation Chemicals Industry PB Ratio | Median Figure of 8 Publicly-Listed Chemicals Companies | 2.5x |
| Russian Federation Market PB Ratio | Median Figure of 150 Publicly-Listed Companies | 0.83x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = MISX:KZOS Share Price ÷ Book Value per Share (both in RUB) = 100.2 ÷ 37.70 |
2.66x |
* Primary Listing of Kazan Organichesky sintez.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Kazan Organichesky sintez is overvalued based on assets compared to the RU Chemicals industry average.
Value checks
We assess Kazan Organichesky sintez's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check) Kazan Organichesky sintez has a total score of 1/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
KZOS Future Performance
- No analysts cover Kazan Organichesky sintez, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Kazan Organichesky sintez's earnings growth is positive but not above the low risk savings rate of 8.4%.
Growth vs Market Checks
- Kazan Organichesky sintez's earnings growth is expected to exceed the Russian Federation market average.
- Unable to compare Kazan Organichesky sintez's revenue growth to the Russian Federation market average as no estimate data is available.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| MISX:KZOS Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts | 4.3% |
| Russian Federation Chemicals Industry Earnings Growth Rate | Market Cap Weighted Average | 12.5% |
| Europe Chemicals Industry Revenue Growth Rate | Market Cap Weighted Average | 3.5% |
| Russian Federation Market Earnings Growth Rate | Market Cap Weighted Average | 3.8% |
| Russian Federation Market Revenue Growth Rate | Market Cap Weighted Average | 4.4% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Date (Data in RUB Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 79,122 | 20,089 | 20,055 |
| 2017-12-31 | 72,106 | 24,725 | 15,029 |
| 2016-12-31 | 75,514 | 12,136 | 17,943 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
All data from Kazan Organichesky sintez Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in RUB Millions) | EPS * |
|---|---|
| 2018-12-31 | 11.23 |
| 2017-12-31 | 8.42 |
| 2016-12-31 | 10.05 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Unable to establish if Kazan Organichesky sintez will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Future performance checks
We assess Kazan Organichesky sintez's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Russian Federation market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Kazan Organichesky sintez has a total score of 1/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
KZOS Past Performance
How has Kazan Organichesky sintez performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Kazan Organichesky sintez has delivered over 20% year on year earnings growth in the past 5 years.
- Kazan Organichesky sintez's 1-year earnings growth is less than its 5-year average (33.4% vs 34.7%)
- Kazan Organichesky sintez's earnings growth has exceeded the RU Chemicals industry average in the past year (33.4% vs -0.4%).
Earnings and Revenue History
All data from Kazan Organichesky sintez Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in RUB Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 79,122.00 | 20,055.00 | 5,659.00 | |
| 2017-12-31 | 72,106.00 | 15,029.00 | 5,986.00 | |
| 2016-12-31 | 75,514.00 | 17,943.00 | 5,036.00 | |
| 2015-12-31 | 68,700.00 | 18,593.00 | 3,255.00 | |
| 2015-09-30 | 65,361.50 | 15,471.00 | 3,074.00 | |
| 2015-06-30 | 62,023.00 | 12,349.00 | 2,893.00 | |
| 2015-03-31 | 58,296.00 | 9,224.00 | 2,886.00 | |
| 2014-12-31 | 54,569.00 | 6,099.00 | 2,879.00 | |
| 2014-09-30 | 52,086.00 | 4,870.00 | 2,896.50 | |
| 2014-06-30 | 49,603.00 | 3,641.00 | 2,914.00 | |
| 2014-03-31 | 47,909.00 | 2,865.50 | 2,803.00 | |
| 2013-12-31 | 46,215.00 | 2,090.00 | 2,692.00 | |
| 2013-09-30 | 46,543.00 | 2,878.50 | 2,557.00 | |
| 2013-06-30 | 46,871.00 | 3,667.00 | 2,422.00 | |
| 2013-03-31 | 46,195.00 | 3,453.50 | 2,511.50 | |
| 2012-12-31 | 45,519.00 | 3,240.00 | 2,601.00 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Kazan Organichesky sintez has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Kazan Organichesky sintez used its assets more efficiently than the RU Chemicals industry average last year based on Return on Assets.
- Kazan Organichesky sintez's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Kazan Organichesky sintez's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Kazan Organichesky sintez has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
KZOS Health
How is Kazan Organichesky sintez's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Kazan Organichesky sintez's finances.
The net worth of a company is the difference between its assets and liabilities.
- Kazan Organichesky sintez is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Kazan Organichesky sintez's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Kazan Organichesky sintez has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Kazan Organichesky sintez Company Filings, last reported 3 months ago.
| Date (Data in RUB Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 67,410.00 | 0.00 | 15,162.00 |
| 2017-12-31 | 54,854.00 | 0.00 | 12,059.00 |
| 2016-12-31 | 48,871.00 | 5,878.00 | 12,287.00 |
| 2015-12-31 | 36,723.00 | 12,408.00 | 17,212.00 |
| 2015-09-30 | 36,723.00 | 12,408.00 | 17,218.00 |
| 2015-06-30 | 27,265.00 | 12,050.00 | 9,791.00 |
| 2015-03-31 | 19,848.00 | 19,749.00 | 10,350.00 |
| 2014-12-31 | 19,848.00 | 19,749.00 | 10,350.00 |
| 2014-09-30 | 19,848.00 | 19,749.00 | 10,350.00 |
| 2014-06-30 | 16,698.00 | 18,018.00 | 3,418.00 |
| 2014-03-31 | 14,368.00 | 18,832.00 | 1,397.00 |
| 2013-12-31 | 14,368.00 | 18,832.00 | 1,397.00 |
| 2013-09-30 | 14,368.00 | 18,832.00 | 1,397.00 |
| 2013-06-30 | 13,674.00 | 20,608.00 | 1,037.00 |
| 2013-03-31 | 13,230.00 | 22,969.00 | 1,618.00 |
| 2012-12-31 | 13,230.00 | 22,969.00 | 1,618.00 |
- Kazan Organichesky sintez has no debt.
- Kazan Organichesky sintez has no debt compared to 5 years ago when it was 131.1%.
- Kazan Organichesky sintez has no debt, it does not need to be covered by operating cash flow.
- Kazan Organichesky sintez has no debt, therefore coverage of interest payments is not a concern.
Financial health checks
We assess Kazan Organichesky sintez's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Kazan Organichesky sintez has a total score of 6/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
KZOS Dividends
What is Kazan Organichesky sintez's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
RUB2,000 of
Kazan Organichesky sintez
shares you are expected to receive
RUB85
in your first year as a dividend.
Dividend Amount
- Kazan Organichesky sintez's pays a higher dividend yield than the bottom 25% of dividend payers in Russian Federation (3.21%).
- Kazan Organichesky sintez's dividend is below the markets top 25% of dividend payers in Russian Federation (9.19%).
Upcoming dividend payment
Purchase Kazan Organichesky sintez before the 'Buy Limit' to receive their next dividend payment.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 0 Analyst Estimates (S&P Global) | See Below |
| Russian Federation Chemicals Industry Average Dividend Yield | Market Cap Weighted Average of 7 Stocks | 10.6% |
| Russian Federation Market Average Dividend Yield | Market Cap Weighted Average of 75 Stocks | 6.8% |
| Russian Federation Minimum Threshold Dividend Yield | 10th Percentile | 1.8% |
| Russian Federation Bottom 25% Dividend Yield | 25th Percentile | 3.2% |
| Russian Federation Top 25% Dividend Yield | 75th Percentile | 9.2% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in RUB) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-03-29 | 4.253 | 4.251 |
| 2018-04-02 | 4.253 | 4.377 |
| 2017-04-11 | 5.073 | 7.026 |
| 2016-03-22 | 3.226 | 7.607 |
| 2015-09-02 | 1.010 | 3.281 |
| 2015-03-30 | 1.011 | 4.546 |
| 2014-08-29 | 0.350 | 3.232 |
| 2014-03-27 | 0.350 | 5.265 |
| 2013-03-28 | 0.540 | 8.900 |
| 2012-04-09 | 0.175 | 3.844 |
| 2011-12-06 | 0.120 | 2.937 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Kazan Organichesky sintez has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Dividend payments have increased, but Kazan Organichesky sintez only paid a dividend in the past 7 years.
Income/ dividend checks
We assess Kazan Organichesky sintez's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Kazan Organichesky sintez afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Kazan Organichesky sintez has a total score of 2/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
KZOS Management
CEO
| AGE | 52 |
| TENURE AS CEO | 6.8 years |
CEO Bio
Mr. Farid Minigulov serves as the Chairman of Executive Board at Open Joint Stock Company Kazanorgsintez and has been its Member of Executive Board since June 27, 2013 and has been its General Director since June 15, 2012 also served as its Executive Directorate. Mr. Minigulov served as Chairman of the Management Board and Deputy Chairman at Open Joint Stock Company Kazanorgsintez. He joined Open Joint Stock Company Kazanorgsintez in 2004 and headed one of its key production facilities, its plant for the production of polycarbonates.
CEO Compensation
- Insufficient data for Farid to compare compensation growth.
- Insufficient data for Farid to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team Tenure
Average tenure and age of the Kazan Organichesky sintez management team in years:
- The average tenure for the Kazan Organichesky sintez management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Farid Minigulov
Chairman of Executive Board
52
6.8 yrs
Fanis Kalimullin
Deputy General Director of Economic & Finance and Member of Executive Board
49
6.3 yrs
Gilazovich Shaikhiev
Member of Executive Board
67
Larisa Kaleva
Chief Accountant & Member of Executive Board
61
Rashit Khafizov
Member of Executive Board
61
Rafael Safarov
Chief Engineer & Member of Executive Board
53
Rinat Zaripov
Deputy General Director of Production & Member of Executive Board
52
6.2 yrs
Albert Gatin
Deputy General Director for Corporate Governance
36
Aleksey Blinov
Deputy General Director of Capital Construction & Overhaul and Member of Executive Board
Gavrilov Victorovich
Head of the Corporate Governance Department
Board of Directors Tenure
Average tenure and age of the Kazan Organichesky sintez board of directors in years:
- The tenure for the Kazan Organichesky sintez board of directors is about average.
Board of Directors
Ruslan Shigabutdinov
Chairman
42
5.7 yrs
Farid Minigulov
Chairman of Executive Board
52
Rinat Sabirov
Director
51
12.8 yrs
Vladimir Presnyakov
Director
67
12.8 yrs
Sergey Alekseev
Director
52
Dmitry Teslenko
Director
57
Marat Garaev
Director
45
Artem Zdunov
Director
Aleksandr Rappoport
Director
2.9 yrs
Milic Zeljko
Director
2.9 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (RUB) | Value (RUB) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Kazan Organichesky sintez's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Kazan Organichesky sintez has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
KZOS News
Simply Wall St News
Is Kazan Public Joint Stock Company Organichesky sintez’s (MCX:KZOS) 33% ROCE Any Good?
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … What is Return On Capital Employed (ROCE)? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleUnderstanding Your Return On Investment In Kazan Public Joint Stock Company Organichesky sintez (MCX:KZOS)
and looking to gauge the potential return on investment in Kazan Public Joint Stock Company Organichesky sintez (MCX:KZOS). … You need to pay attention to this because your return on investment is linked to dividends and internal investments to improve the business, which can only occur if the company is expected to produce adequate earnings with the capital that has been provided. … Therefore, looking at how efficiently Kazan Organichesky sintez is able to use capital to create earnings will help us understand your potential return.
Simply Wall St - – Full articleDoes Kazan Public Joint Stock Company Organichesky sintez's (MCX:KZOS) PE Ratio Warrant A Sell?
By comparing a stock’s price per share to its earnings per share, we are able to see how much investors are paying for each dollar of the company’s earnings. … Formula Price-Earnings Ratio = Price per share ÷ Earnings per share P/E Calculation for KZOS Price per share = RUB92.9 Earnings per share = RUB8.419 ∴ Price-Earnings Ratio = RUB92.9 ÷ RUB8.419 = 11x On its own, the P/E ratio doesn’t tell you much; however, it becomes extremely useful when you compare it with other similar companies. … For example, if you are inadvertently comparing riskier firms with KZOS, then KZOS’s P/E would naturally be higher than its peers since investors would reward its lower risk with a higher price.
Simply Wall St - – Full articleKazan Public Joint Stock Company Organichesky sintez (MCX:KZOS): What Are Investors Earning On Their Capital?
Therefore, looking at how efficiently Kazan Organichesky sintez is able to use capital to create earnings will help us understand your potential return. … To determine Kazan Organichesky sintez's capital return we will use ROCE, which tells us how much the company makes from the capital employed in their operations (for things like machinery, wages etc). … This shows Kazan Organichesky sintez provides a great return on capital employed that is well above the 15% ROCE that is typically considered to be a strong benchmark.
Simply Wall St - – Full articleWho Really Owns Kazan Public Joint Stock Company Organichesky sintez (MCX:KZOS)?
In this article, I'm going to take a look at Kazan Public Joint Stock Company Organichesky sintez’s (MISX:KZOS) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … A company's ownership structure is often linked to its share performance in both the long- and short-term. … See our latest analysis for Kazan Organichesky sintez MISX:KZOS Ownership_summary Apr 27th 18 Institutional Ownership Institutional investors are one of the largest group of market participants and their buy-sell decisions on a company's stock can significantly impact prices, more so, when there are relatively small amounts of shares available on the market to trade.
Simply Wall St - – Full articleCan Kazan Public Joint Stock Company Organichesky sintez's (MCX:KZOS) ROE Continue To Surpass The Industry Average?
View our latest analysis for Kazan Organichesky sintez Breaking down ROE — the mother of all ratios Return on Equity (ROE) weighs Kazan Organichesky sintez’s profit against the level of its shareholders’ equity. … Kazan Organichesky sintez’s cost of equity is 13.41%. … This is called the Dupont Formula: Dupont Formula ROE = profit margin × asset turnover × financial leverage ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity) ROE = annual net profit ÷ shareholders’ equity MISX:KZOS Last Perf Apr 20th 18 Basically, profit margin measures how much of revenue trickles down into earnings which illustrates how efficient the business is with its cost management.
Simply Wall St - – Full articleWhat You Must Know About Kazan Public Joint Stock Company Organichesky sintez's (MCX:KZOS) Financial Health
With this debt payback, the current cash and short-term investment levels stands at RUРУБ12.29B , ready to deploy into the business. … Additionally, KZOS has generated cash from operations of RUРУБ12.14B during the same period of time, resulting in an operating cash to total debt ratio of 206.46%, indicating that KZOS’s operating cash is sufficient to cover its debt. … Next Steps: KZOS has demonstrated its ability to generate sufficient levels of cash flow, while its debt hovers at a safe level.
Simply Wall St - – Full articleShould Kazan Public Joint Stock Company Organichesky sintez's (MCX:KZOS) Recent Earnings Decline Worry You?
For Kazan Organichesky sintez, its most recent earnings (trailing twelve month) is RUРУБ17.94B, which, relative to the prior year's figure, has declined by -3.49%. … Since these figures may be relatively short-term, I’ve determined an annualized five-year value for KZOS's net income, which stands at RUРУБ7.10B This shows that even though earnings declined from the previous year, over the past couple of years, Kazan Organichesky sintez's earnings have been increasing on average. … This means that whatever recent headwind the industry is experiencing, Kazan Organichesky sintez is relatively better-cushioned than its peers.What does this mean?
Simply Wall St - – Full articleKZOS Company Info
Description
Kazan Public Joint Stock Company Organichesky sintez, together with its subsidiaries, produces and sells chemical products in Russia. The company offers high and medium density, linear low density, and bimodal high density polyethylene; polyethylene pipes and fittings for gas and water supply; butane-1, which is used as a comonomer-modifier for high and medium density LPPE, and linear low density polyethylene productions; polyethylene compositions for the production of cord items shells, high-speed extrusion, rotary molding production, and polyethylene cable compositions. It also provides phenol for producing caprolactam, diphenylpropane, medicines, synthetic resins, plasticizers, and herbicides; acetone for producing acetic anhydride, acetonecyanhydrine, and diphenylolpropane, as well as for use as a solvent in various industrial applications; and bisphenol-A for the production of polycarbonate, and bromated combustion inhibitors and stabilizers for various polymers, as well as epoxide, polysulfone, polyarylate, special phenolic, polyester imidic, and unsaturated ester resins. In addition, the company offers polycarbonates used for the production of automotive head lamps, optical lenses, compact discs, helmets, and blood filters, as well as high-precision parts, such as pinions, bushings, etc.; and polycarbonate sheets for producing multi-layer glasses used in buildings, sport facilities, and greenhouses glazing. Further, it provides ethylene that is used as feed stock for propylene and ethylene oxide; propylene used for the production of polypropylene, phenol, acetone, and propylene oxide; and ethylene oxide glycols, ethanolamines, cooling liquids, textile agents, products for the preparation of oil-corrosion and paraffin deposits inhibitors, proxanols-proxamines, and demulsifiers. The company was founded in 1958 and is based in Kazan, Russia. Kazan Public Joint Stock Company Organichesky sintez is a subsidiary of OOO Telecom-Management.
Details
| Name: | Kazan Public Joint Stock Company Organichesky sintez |
| KZOS | |
| Exchange: | MISX |
| Founded: | 1958 |
| RUB178,868,422,800 | |
| 1,785,114,000 | |
| Website: | http://www.kazanorgsintez.ru |
| Address: |
Kazan Public Joint Stock Company Organichesky sintez Belomorskaya street, 101, Kazan, Tatarstan, 420051, Russia |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| MISX | KZOS | Ordinary Shares | Micex - Rts | RU | RUB | 28. Mar 2000 | |
| MISX | KZOSP | RUB1 PRF(RUB) | Micex - Rts | RU | RUB | 03. Feb 2012 |
Number of employees
Current staff
Industry
| Commodity Chemicals | |
| Materials |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/18 21:33 |
| End of day share price update: | 2019/04/18 00:00 |
| Last earnings filing: | 2019/03/29 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
